ProfileOfResearchers

TÃTULO: Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF? Full Text
AUTORES: Neves, Joao Sergio ; Zannad, Faiez; Butler, Javed; Packer, Milton; Ferreira, Joao Pedro ;
PUBLICAÇÃO: 2024, FONTE: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, VOLUME: 84, NÚMERO: 12

INDEXADO EM:

Scopus

WOS

TÃTULO: The Win Ratio for Composite Outcomes in Nephrology Clinical Trials
AUTORES: Ferreira, Joao Pedro ; Zannad, Faiez;
PUBLICAÇÃO: 2024, FONTE: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

INDEXADO EM:

Scopus

WOS

TÃTULO: Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE Full Text
AUTORES: Ferreira, Joao Pedro ; Blatchford, Jonathan P.; Teerlink, John R.; Kosiborod, Mikhail N.; Angermann, Christiane E.; Biegus, Jan; Collins, Sean P.; Tromp, Jasper; Nassif, Michael E.; Psotka, Mitchell A.; Comin Colet, Josep; Mentz, Robert J.; Brueckmann, Martina; Nordaby, Matias; Ponikowski, Piotr; Voors, Adriaan A.;
PUBLICAÇÃO: 2024, FONTE: EUROPEAN JOURNAL OF HEART FAILURE

INDEXADO EM:

Scopus

WOS

TÃTULO: Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction Full Text
AUTORES: Doehner, Wolfram; Anker, Stefan D.; Butler, Javed; Zannad, Faiez; Filippatos, Gerasimos; Coats, Andrew J. S.; Ferreira, Joao Pedro ; Henrichmoeller, Ingrid; Brueckmann, Martina; Schueler, Elke; Pocock, Stuart J.; Januzzi, James L.; Packer, Milton;
PUBLICAÇÃO: 2024, FONTE: JACC-HEART FAILURE, VOLUME: 12, NÚMERO: 12

INDEXADO EM:

Scopus

WOS

TÃTULO: A machine learning-derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial Full Text
AUTORES: Kobayashi, Masatake; Huttin, Olivier; Ferreira, Joao Pedro ; Duarte, Kevin; Gonzalez, Arantxa; Heymans, Stephane; Verdonschot, Job A. J.; Brunner La Rocca, Hans Peter; Pellicori, Pierpaolo L.; Clark, Andrew; Petutschnigg, Johannes; Edelmann, Frank G.; Cleland, John; Rossignol, Patrick; Zannad, Faiez; Girerd, Nicolas;
PUBLICAÇÃO: 2023, FONTE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 25, NÚMERO: 8

INDEXADO EM:

Scopus

WOS

NO MEU:

ORCID |

TÃTULO: Association between a hospitalization for heart failure and the initiation/discontinuation of guideline‐recommended treatments: An analysis from the Swedish Heart Failure Registry Full Text
AUTORES: Benedikt Schrage; Lars H Lund; Lina Benson; Frieder Braunschweig; João Pedro Ferreira ; Ulf Dahlström; Marco Metra; Giuseppe M.C Rosano; Gianluigi Savarese;
PUBLICAÇÃO: 2023, FONTE: European Journal of Heart Failure, VOLUME: 25, NÚMERO: 7

INDEXADO EM:

CrossRef: 12

NO MEU:

ORCID |

TÃTULO: Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure
AUTORES: Packer, Milton; Butler, Javed; Zeller, Cordula; Pocock, Stuart J.; Brueckmann, Martina; Ferreira, Joao Pedro ; Filippatos, Gerasimos; Usman, Muhammad Shariq; Zannad, Faiez; Anker, Stefan D.;
PUBLICAÇÃO: 2023, FONTE: CIRCULATION, VOLUME: 148, NÚMERO: 13

INDEXADO EM:

WOS

NO MEU:

ORCID |

TÃTULO: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: insights from the EMPEROR-Preserved trial Full Text
AUTORES: Sharma, Abhinav; Ferreira, Joao Pedro ; Zannad, Faiez; Pocock, Stuart J.; Filippatos, Gerasimos; Pfarr, Egon; Petrini, Michaela; Kraus, Bettina J.; Wanner, Christoph; Packer, Milton; Butler, Javed; Anker, Stefan D.;
PUBLICAÇÃO: 2023, FONTE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 25, NÚMERO: 8

INDEXADO EM:

Scopus

WOS

NO MEU:

ORCID |